Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-05-28
1987-06-23
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514557, 514717, A61K 3155, A61K 3119, A61K 31075
Patent
active
046753184
ABSTRACT:
A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.
REFERENCES:
patent: 4152333 (1979-05-01), Mikolajczak
patent: 4206221 (1980-06-01), Miller
Merck Index, 10th ed., #6705 and 4284, 1983.
A translation of an article entitled Clinical Observations on Forty Cases Nonlymphatic Leukemia with Treatment of Homoharringtonine and Harringtonine, by L. H. Lou and C. H. Chen, Journal of Chinese Internal Medicine 3:162-164, 1978.
Original copies of Journal of Chinese Internal Medicine 3:162-164, 1978.
Brown Johnnie R.
Rollins Jr. John W.
LandOfFree
Safe antileukemia drug, SAL does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Safe antileukemia drug, SAL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Safe antileukemia drug, SAL will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-721354